Login
← Go Back
Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024
Stock Price vs Company Growth
1d
1.4%
1w
0.9%
1m
5.5%
3m
3.3%
all
2.6%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowLatest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 745 1.4%
640
803
Company Overview
Sales
1,591 Cr
Growth: 0.0%
Profit after Tax
173 Cr
Growth: 9.0%
Mid Cap
15,536 Cr
P/E: 79.7x
Industry P/E: 32.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 1,591
Growth 0.0%
EBITDA 25.7%
P/S 9.8x
Dividend 0.0%
P/E 79.7x
Book Value ₹ 1
PEG Ratio N/A
ROE 921.9%
P/B N/A
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Belongs to (13 Indices) view more
Followers (1)
varsha96